{"mainPropery":{"diseaseId":9962,"diseaseName":"Lentigo maligna melanoma","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/9962/lentigo-maligna-melanoma","synonyms":["LMM","Hutchison melanotic freckle"],"synonyms-with-source":[{"name":"LMM"},{"name":"Hutchison melanotic freckle"}],"identifiers":[]},"diseaseCategories":[{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"}],"organizations":[{"resourceID":4293,"resourceName":"Melanoma Research Alliance","abbreviation":"MRA","address1":"730 15th Street, NW","address2":"","address3":"","address4":"","address5":"","city":"Washington","state":"DC","zip":"20005","country":"United States","phone":"+1-202-336-8935","tty":"","tollFree":"","fax":"","email":" info@curemelanoma.org","url":"https://www.curemelanoma.org/","freeText":""}],"resource descriptions":[{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/279839-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1543,"resourceId":2171,"resourceName":"National Cancer Institute","descriptionText":"The <a href='http://www.cancer.gov/cancertopics/types/melanoma' target='_blank'>National Cancer Institute</a> provides the most current information on cancer for patients, health professionals, and the general public.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2160,"resourceId":3368,"resourceName":"Patient Access Network Foundation","descriptionText":"<a href='https://panfoundation.org/index.php/en/patients/assistance-programs/melanoma' target='_blank'>Patient Access Network Foundation</a> (PAN Foundation) has Assistance Programs for those with health insurance who reside in the United States. The disease fund status can change over time, so you may need to check back if funds are not currently available.&nbsp;","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":2161,"resourceId":3369,"resourceName":"HealthWell Foundation","descriptionText":"The <a href='http://www.healthwellfoundation.org/melanoma' target='_blank'>HealthWell Foundation</a> provides financial assistance for underinsured patients living with chronic and life-altering conditions. They offer help with drug copayments, deductibles, and health insurance premiums for patients with specific diseases. The disease fund status can change over time, so you may need to check back if funds are not currently available.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":2162,"resourceId":3371,"resourceName":"The Assistance Fund","descriptionText":"<a href='https://tafcares.org/patients/covered-diseases/' target='_blank'>The Assistance Fund</a> provides various services, including education and financial aid, to help patients with a chronic or serious illness cover the cost of FDA-approved medications. Patients must be U.S citizens or permanent residents.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":2163,"resourceId":3372,"resourceName":"Good Days","descriptionText":"<a href='https://www.mygooddays.org/patients/diseases-covered/chronic-iron-overload' target='_blank'>Good Days</a> provides help to patients with life-altering conditions. Assistance includes help with the cost of medications and travel.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"}],"overviewQuestion":{"questionId":6545,"questionText":"What is lentigo maligna melanoma (LMM)?","answerText":"<strong>Lentigo maligna melanoma (LMM)</strong> is a type of skin cancer that usually develops in older, fair-skinned&nbsp;adults.&nbsp; The average age of diagnosis is&nbsp;65.&nbsp; LMM is thought to be caused by a history of sun exposure to the affected area.&nbsp; Treatment includes surgery to remove as much of the LMM as possible.[5634]<br>","dateModified":"2012-11-23T07:12:00"},"basicQuestions":[],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":37313,"abbreviatedInquiry":"If you are diagnosed with&nbsp;lentigo maligna melanoma (LMM),&nbsp;what are the chances of having another, completely separate LMM at another site?&nbsp; Is LMM genetic?","caseQuestions":[{"questionId":6546,"questionText":"Can a person&nbsp;develop multiple&nbsp;lentigo maligna melanoma in different parts of the body?","answerText":"Yes.&nbsp; Up to 8% of all individuals with some type of melanoma go on to develop a second melanoma.&nbsp; Lentigo maligna melanoma has been found to be a risk factor for developing a second melanoma, typically in a part of the body that has a history of&nbsp;significant sun exposure.[5633]","dateModified":"2012-11-23T07:15:00","references":[{"referenceId":5633,"authors":"Savoia P, Quaglino P, Verrone A, Bernengo MG","articleTitle":"","bookWebsiteJournalTitle":"Melanoma Research","date":"1998","volume":"8","pages":"361-366","url":"http://www.ncbi.nlm.nih.gov/pubmed/9764812","dateAccessed":"2012-11-22T00:00:00"}]},{"questionId":6547,"questionText":"Is lentigo maligna melanoma genetic?","answerText":"Lentigo maligna melanoma (LMM) is not believed to be inherited (arising from a <a href=\"https://ghr.nlm.nih.gov/primer/mutationsanddisorders/predisposition\" target=_blank>genetic predisposition</a>).&nbsp; LMM is thought to be caused by a history of significant sun exposure.[5635]","dateModified":"2012-11-23T07:19:00","references":[{"referenceId":5635,"authors":"Anderson WF, Pfeiffer RM, Tucker MA, Rosenberg PS","articleTitle":"Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma","bookWebsiteJournalTitle":"Cancer","date":"2009","volume":"115","pages":"4176-4185","url":"http://www.ncbi.nlm.nih.gov/pubmed/19536874","dateAccessed":"2012-11-22T00:00:00"}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[{"productId":121,"genericName":"Aldesleukin","tradeName":"Proleukin","tradeLink":"https://www.proleukin.com/","manufacturer":"","sponsor":"Chiron Corporation","indication":"Treatment of adults with metastatic melanoma.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/Proleukin","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a692009.html"}],"EncodedName":"Lentigo_maligna_melanoma"}